Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists

Key facts

Sponsor

AstraZeneca

Principal Investigator

Ron M.C. Herings, PhD

PHARMO Institute for Drug Outcome Research, Utrecht, The Netherlands

Enrollment

23470 enrolled

Eligibility

All sexes

Timeline

2011 – 2015

Study locations (1)

• Reserach Site, Utrecht, Netherlands

Collaborators

PHARMO Institute for Drug Outcome Research

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute interstitial pneumonia

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGNANCT06526884
  Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
  University of California, Los Angeles
• RECRUITINGNCT05681962
  Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy
  University Magna Graecia

See all trials for Acute interstitial pneumonia →